Found: 47
Select item for more details and to access through your institution.
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7565, doi. 10.1007/s00432-023-04678-2
- By:
- Publication type:
- Article
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5591, doi. 10.1007/s00432-022-04512-1
- By:
- Publication type:
- Article
Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act.
- Published in:
- BMC Palliative Care, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12904-021-00759-6
- By:
- Publication type:
- Article
Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study.
- Published in:
- BMC Palliative Care, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12904-021-00749-8
- By:
- Publication type:
- Article
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 9, p. 7431, doi. 10.1007/s00520-022-07143-x
- By:
- Publication type:
- Article
Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5383, doi. 10.1007/s00520-021-06127-7
- By:
- Publication type:
- Article
Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221148541
- By:
- Publication type:
- Article
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113266
- By:
- Publication type:
- Article
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CD45<sup>dim</sup>CD34<sup>+</sup>CD38<sup>-</sup>CD133<sup>+</sup> cells have the potential as leukemic stem cells in acute myeloid leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
"Teachable Moment": Effects of an Educational Program on Knowledge and Quality of Life of Korean Breast Cancer Survivors.
- Published in:
- Journal of Cancer Education, 2022, v. 37, n. 3, p. 812, doi. 10.1007/s13187-020-01888-x
- By:
- Publication type:
- Article
Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 721, doi. 10.4143/crt.2023.1043
- By:
- Publication type:
- Article
ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1291, doi. 10.4143/crt.2022.1450
- By:
- Publication type:
- Article
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 1, doi. 10.4143/crt.2021.1115
- By:
- Publication type:
- Article
Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1632, doi. 10.4143/crt.2019.009
- By:
- Publication type:
- Article
Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035983
- By:
- Publication type:
- Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article
Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035983
- By:
- Publication type:
- Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923424
- By:
- Publication type:
- Article
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5985, doi. 10.3390/cancers14235985
- By:
- Publication type:
- Article
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5834, doi. 10.3390/cancers14235834
- By:
- Publication type:
- Article
Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1747, doi. 10.3390/cancers14071747
- By:
- Publication type:
- Article
LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0247368
- By:
- Publication type:
- Article
Perceptions of the meaning of life among Korean patients with advanced cancer: A mixed-methods study.
- Published in:
- Palliative & Supportive Care, 2023, v. 21, n. 4, p. 658, doi. 10.1017/S1478951522000979
- By:
- Publication type:
- Article
Organ‐specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1961, doi. 10.1111/liv.15935
- By:
- Publication type:
- Article
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 3, p. 674, doi. 10.1111/liv.15102
- By:
- Publication type:
- Article
Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2544, doi. 10.1111/liv.14573
- By:
- Publication type:
- Article
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events.
- Published in:
- Liver International, 2020, v. 40, n. 9, p. 2263, doi. 10.1111/liv.14496
- By:
- Publication type:
- Article
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 522, doi. 10.1159/000537915
- By:
- Publication type:
- Article
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 89, doi. 10.1159/000531182
- By:
- Publication type:
- Article
Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 613, doi. 10.1159/000508901
- By:
- Publication type:
- Article
Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2731, doi. 10.1002/cam4.5161
- By:
- Publication type:
- Article
α‐FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 6, p. 1043, doi. 10.1002/ijc.34799
- By:
- Publication type:
- Article
Early Integrated Palliative Care in Patients With Advanced Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2426304, doi. 10.1001/jamanetworkopen.2024.26304
- By:
- Publication type:
- Article
The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathway.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92651-9
- By:
- Publication type:
- Article
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2‐negative metastatic breast cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 4, p. 917, doi. 10.1002/ijc.33613
- By:
- Publication type:
- Article
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 4, p. 794, doi. 10.1007/s10120-022-01298-6
- By:
- Publication type:
- Article
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 4, p. 645, doi. 10.1007/s11523-024-01061-0
- By:
- Publication type:
- Article
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 1, p. 29, doi. 10.1007/s11523-023-01029-6
- By:
- Publication type:
- Article
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
- Published in:
- Targeted Oncology, 2023, v. 18, n. 2, p. 221, doi. 10.1007/s11523-023-00953-x
- By:
- Publication type:
- Article
Management of the adverse effects of cancer immunotherapy with a focus on the gastrointestinal and hepatic systems.
- Published in:
- Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2023, v. 66, n. 2, p. 112, doi. 10.5124/jkma.2023.66.2.112
- By:
- Publication type:
- Article
High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 6, p. 935, doi. 10.7150/jca.81384
- By:
- Publication type:
- Article
Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea.
- Published in:
- Journal of Cancer, 2022, v. 13, n. 13, p. 3396, doi. 10.7150/jca.74107
- By:
- Publication type:
- Article
Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study.
- Published in:
- BMC Medical Ethics, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12910-023-00897-x
- By:
- Publication type:
- Article